Momenta, the leading Industrial Impact venture capital firm, has led a Series A investment round in DataHow, a Zurich-based company specializing in AI-powered solutions for bioprocess development and manufacturing. Founded in 2017 by ETH researchers Dr. Alessandro Butt and Dr. Michael Sokolov, DataHow has been at the forefront of developing hybrid models that integrate data-driven AI algorithms with hard-coded process knowledge. This innovative approach provides richer insights into bioprocesses while requiring less data. The recent investment by Momenta, along with Rockwell Automation and Zrcher Kantonalbank, will accelerate the deployment of DataHow’s digital bioprocessing platform, DataHowLab. The funding underscores the transformative potential of DataHow’s technology in the biopharmaceutical industry’s digitalization efforts. Key benefits anticipated include accelerated process development, increased manufacturing productivity, and enhanced process monitoring and control through digital twin technology. This investment is also notable as it marks the second funding recipient from Momenta’s Digital Industry Fund IV.

Venture Capital, Biotechnology, Industrial Automation,Switzerland, United States